Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Drug overcomes chemotherapy resistance in ovarian cancer
An international research team, led by scientists from Mater Research—The University of Queensland, have discovered…
Increased rate of infections may indicate a future cancer diagnosis
New research published in Cancer Immunology Research, a journal of the American Association for Cancer Research,…
Blood test may help doctors catch pancreatic cancer early
A blood test may be able to detect the most common form of pancreatic cancer…
The fourth pillar
The fourth pillar: how we’re arming the immune system to help fight cancer By Joseph Trapani, Peter MacCallum Cancer Centre. The past…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.